Mainz Biomed BV (MYNZ)

NASDAQ
11.10
-0.81(-6.80%)
  • Volume:
    6,338
  • Day's Range:
    11.02 - 11.65
  • 52 wk Range:
    7.80 - 30.00

MYNZ Overview

Prev. Close
11.91
Day's Range
11.02-11.65
Revenue
-
Open
11.51
52 wk Range
7.8-30
EPS
-
Volume
6,338
Market Cap
154.96M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
46,526
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
13,960,487
Next Earnings Date
-
What is your sentiment on Mainz Biomed BV?
or
Market is currently closed. Voting is open during market hours.

Mainz Biomed BV News

Mainz Biomed BV Company Profile

Mainz Biomed BV Company Profile

Employees
0

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellBuy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellBuy
SummaryStrong SellStrong SellStrong SellStrong SellBuy
  • This stock *****
    0